Latest News
Frontier IP investment completes initial trials of raspberry-picking robot
University intellectual property commercialisation specialist Frontier IP Group announced on Tuesday that its portfolio company, Fieldwork Robotics, has completed initial field trials of its robot raspberry harvesting system.
Canaccord raises target on Kainos following trading update
Analysts at Canaccord Genuity upped their target price on digital technology solutions firm Kainos from 590p to 660p on Tuesday, noting that the consensus forecasts for growth and margins both looked "conservative".
FTSE 100 movers: NMC rallies on earnings upgrade; tobacco stocks drop
London's FTSE 100 was 0. 2% higher at 7,294. 30 in afternoon trade on Tuesday.
Alibaba plans to raise $20bn through Hong Kong listing
Alibaba is considering raising as much as $20bn through a second listing on the Hong Kong Stock Exchange after its 2014 record-breaking stock market debut in New York that saw it raise $25bn.
US home price growth cools further in March, S&P says
Home price growth in the States cooled down further in March, according to the results of a widely-followed survey.
Diurnal Group launches placing and open offer to fund drug development
Specialty pharmaceutical company Diurnal Group announced a conditional placing of new ordinary shares in the company and the launch of an open offer on Tuesday, in order to raise funds to progress the development and commercialisation of its products.
Comptoir Group says trading in line, sales ahead of last year
Comptoir Group, the owner of the Comptoir Libanais restaurant chain, said on Tuesday that it continues to trade in line with management's expectations.
Silence Therapeutics enters into collaboration with Genomics England
Novel therapeutics developer Silence Therapeutics has entered into a collaboration with Genomics England for the investigation of novel targets involved in human disease, it announced on Tuesday.
Asiamet to progress with strategy after ASIPAC investment
Asiamet Resources announced a $2m private placement to key shareholder ASIPAC on Tuesday, and proposed that an ASIPAC representative would join its board as a non-executive director, effective 1 July.
Novo Holdings pours £53.5m into Oxford Biomedica
Gene and cell therapy company Oxford Biomedica announced on Tuesday that Novo Holdings has agreed to invest up to £53. 5m in the group, in return for new ordinary shares representing up to 10. 1% of the outstanding shares after the capital increase.
Albert Technologies warns of slower than anticipated revenues
Software firm Albert Technologies warned that year-to-date revenue growth had been slower than anticipated, mainly as a result of longer ramp-up times for its enterprise clients.
Gove promises free UK citizenship for 3.0m EU nationals if he becomes PM
Michael Gove is set to announce on Tuesday a pledge to grant free British citizenship for 3. 0m EU nationals and to abolish the need to prove settled status after Brexit if he replaces Theresa May as Prime Minister.
Asia report: Most markets rise after Trump visits Japan
Most markets in Asia finished in the green on Tuesday, as markets digested the aftermath of a state visit to Japan by US president Donald Trump.
ClearStar appoints Jennifer Balleza as permanent CFO
Medical screening specialist ClearStar made Jennifer Balleza its permanent chief financial officer on Tuesday after having served in the role on an interim basis since January.
US pre-open: Futures point to slightly negative start with trade woes in focus
US futures were pointing to small losses at the bell following the Memorial Day long weekend, with investors still focussed on the trade spat between the world's two largest economies.
Chain division boosts profits at Renold
Renold posted a rise in full-year operating profit and revenue on Tuesday thanks to strong growth in its chain division.
Flybe CEO Ourmieres-Widener to step down in July
Flybe said on Tuesday that chief executive officer Christine Ourmieres-Widener will step down from the company on 15 July.
Europe midday: Italian issues underperform, Greece in focus
Shares on the Continent were little changed overall, although Italian stocks remained under selling pressure as investors reacted to reports that Brussels might be set to slap a fine on Italy over its public finances.
Jefferies reiterates 'buy' on Burford Capital, says value of Petersen recoveries underestimated
Analysts at Jefferies reiterated their 'buy' recommendation for shares of Burford Capital, pointing out to clients that the company's share of the legal recoveries from the Petersen investment might reach $2. 5bn, which would equate to 55% of the company's market capitalisation.